Glioblastoma multiforme is a uniquely resistant tumor to conventional surgery, radiation and chemotherapy. The 5-year disease free survival rate is greater than 2%. Virtually all of the deaths are due to progressive growth of tumor or the complication of treatment. For essentially all other human tumors there is a clearly recognizable local control rate following 60-70 Gy (at approximately 2 Gy per fraction) where tumors of comparable sizes are treated. The broad objective of the proposed research is to determine the extent to which the extraordinary resistance of GBMs is the consequence of: inherent cellular radiation resistance; unusually high numbers of Tumor Rescue Units per unit volume, micro-metabolic conditions which produce resistance (e.g., hypoxia) and or increase repair of radiation damage (e.g., high SH levels); rapid proliferation of tumor cells. The plan is to determine the values of the parameters alpha,beta, D(O), n, SF(2), and D for a large series of GBM and SCC cell lines. Concurrently, determine: the TCD-50-s, fractionation sensitivities, SF-6H, TRU numbers in xenografts, and the metabolic profile of these same xenografts. This latter planned work will require active collaboration with several investigators at other institutions with special technical capabilities and research interest in tumor pathophysiology. A secondary aim is to characterize the nude and scid mouse in terms of its residual immune reactivity after immune suppressive procedures (whole body irradiation, administration if immune suppressive agents, e.g., ALS, induction of immune tolerance, etc.).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA013311-27
Application #
2607969
Study Section
Special Emphasis Panel (NSS)
Program Officer
Mahoney, Francis J
Project Start
1975-10-01
Project End
1999-07-31
Budget Start
1997-12-01
Budget End
1999-07-31
Support Year
27
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Kozin, Sergey V; Niemierko, Andrzej; Huang, Peigen et al. (2008) Inter- and intramouse heterogeneity of radiation response for a growing paired organ. Radiat Res 170:264-7
Pardo, F S; Hsu, D W; Zeheb, R et al. (2004) Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. Br J Cancer 91:1678-86
Kozin, S V; Shkarin, P; Gerweck, L E (2001) The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics. Cancer Res 61:4740-3
Chastagner, P; Kozin, S V; Taghian, A (2001) Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice. Int J Radiat Oncol Biol Phys 50:777-82
Hartford, A C; Gohongi, T; Fukumura, D et al. (2000) Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res 60:2128-31
Griffon-Etienne, G; Boucher, Y; Brekken, C et al. (1999) Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res 59:3776-82
Budach, W; Gioioso, D; Taghian, A et al. (1997) Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys 39:743-50
Griffon-Etienne, G; Boucher, Y; Jain, R K et al. (1997) Effects of needle insertion in tumors on interstitial fluid pressure. Microvasc Res 54:174-7
Huang, P; Taghian, A; Hsu, D W et al. (1996) Spontaneous metastasis, proliferation characteristics and radiation sensitivity of fractionated irradiation recurrent and unirradiated human xenografts. Radiother Oncol 41:73-81
Huang, P; Taghian, A; Allam, A et al. (1996) The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograft. Radiat Res 145:337-42

Showing the most recent 10 out of 77 publications